The clinical experience of Gynipral application in pregnant and during labor

Cover Page


Cite item

Full Text

Abstract

In modern obstetrics there is an urgent problem of treatment of threat of premature labor being one of the basic reasons for perinatal losses. In the article the prospects of Gynipral application in pregnant women, and also the results of practical application of a drug in clinic are considered. It is proved, that the application of beta-adrenomimetic Gynipral allows effectively and without development of complications on the part of the mother to carry out the treatment of premature labor threat, hypoxia a fetus, discoordination in labor, that provides the perinatal morbidity and mortality reduction.

About the authors

M. A. Repina

Pavlov State Medical University

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg

N. V. Kulagina

Pavlov State Medical University

Email: info@eco-vector.com
Russian Federation, St. Petersburg

Ya. A. Kornilova

Pavlov State Medical University

Email: info@eco-vector.com
Russian Federation, St. Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Cardiotocogram of pregnant M. Pathological preterminal period (after intravenous administration of gynipral).

Download (2MB)
3. Fig. 2. Cardiotocogram of pregnant I. Discoordinated labor (before gynipral).

Download (2MB)
4. Fig. 3. Cardiotocogram of pregnant I. (after intravenous gynipral).

Download (3MB)
5. Fig. 4. Cardiotocogram of pregnant Z. Fetal distress before gynipral).

Download (2MB)
6. Fig. 5. Cardiotocogram of pregnant Z. (after intravenous gynipral).

Download (2MB)

Copyright (c) 1999 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).